NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea
· Delayed Price · Currency is KRW 19,450
-250 (-1.27%)
At close: Dec 5, 2025
NeoPharm CO., LTD. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 27,797 | 23,065 | 23,213 | 17,027 | 17,713 | 18,131 | Upgrade
|
| Depreciation & Amortization | 3,102 | 3,150 | 1,673 | 1,616 | 1,500 | 1,494 | Upgrade
|
| Loss (Gain) From Sale of Assets | -52.63 | 17.17 | 3.7 | 6.05 | 3.23 | 10.81 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.3 | 3.3 | 13.47 | 6.23 | 11.07 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -309.6 | -251.15 | 2.76 | - | -48.48 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -5.37 | 320.68 | 95.42 | -0.11 | 55.48 | -9.69 | Upgrade
|
| Other Operating Activities | -820.32 | -336.03 | 834.24 | 896.16 | 1,416 | 1,928 | Upgrade
|
| Change in Accounts Receivable | -131.33 | -2,329 | -2,109 | 855.53 | 972.12 | 544.96 | Upgrade
|
| Change in Inventory | -183.96 | -3,443 | -1,840 | -1,108 | -94.7 | -2,831 | Upgrade
|
| Change in Accounts Payable | 1,918 | -1,405 | 2,732 | -643.79 | 152.91 | 1,020 | Upgrade
|
| Change in Other Net Operating Assets | -1,401 | -161.29 | -1,355 | -494.97 | 0.34 | -3,214 | Upgrade
|
| Operating Cash Flow | 29,915 | 18,631 | 23,263 | 18,161 | 21,681 | 17,074 | Upgrade
|
| Operating Cash Flow Growth | 85.04% | -19.91% | 28.09% | -16.24% | 26.98% | -11.19% | Upgrade
|
| Capital Expenditures | -1,228 | -2,799 | -19,852 | -454 | -320.11 | -285.62 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.2 | - | 0.91 | 0.15 | 0.85 | 0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | -17.85 | -277.99 | -975.96 | -352.43 | -158 | -444.74 | Upgrade
|
| Investment in Securities | -6,228 | -3,136 | 4,487 | -8,000 | -16,002 | -4,000 | Upgrade
|
| Other Investing Activities | -1,011 | -18.97 | 4.02 | 8.57 | -203.9 | 19.51 | Upgrade
|
| Investing Cash Flow | -8,671 | -6,225 | -16,353 | -8,800 | -16,689 | -4,739 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -4,000 | -400 | Upgrade
|
| Long-Term Debt Repaid | - | -598.23 | -534.03 | -494.56 | -373.42 | -320.2 | Upgrade
|
| Total Debt Repaid | -644.53 | -598.23 | -534.03 | -494.56 | -4,373 | -720.2 | Upgrade
|
| Net Debt Issued (Repaid) | -644.53 | -598.23 | -534.03 | -494.56 | -4,373 | -720.2 | Upgrade
|
| Dividends Paid | -9,385 | -5,865 | -5,474 | -5,474 | -5,083 | -5,865 | Upgrade
|
| Other Financing Activities | 70.59 | -31.47 | 91.79 | 218.63 | -62.13 | 16.24 | Upgrade
|
| Financing Cash Flow | -9,959 | -6,495 | -5,917 | -5,750 | -9,519 | -6,569 | Upgrade
|
| Foreign Exchange Rate Adjustments | 274.89 | 442.71 | 4.78 | 223.43 | 387.01 | -91.54 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 11,561 | 6,353 | 998.06 | 3,834 | -4,140 | 5,673 | Upgrade
|
| Free Cash Flow | 28,687 | 15,832 | 3,411 | 17,707 | 21,361 | 16,788 | Upgrade
|
| Free Cash Flow Growth | - | 364.17% | -80.74% | -17.11% | 27.24% | 26.02% | Upgrade
|
| Free Cash Flow Margin | 22.10% | 13.30% | 3.51% | 20.82% | 24.29% | 20.57% | Upgrade
|
| Free Cash Flow Per Share | 1834.09 | 1012.16 | 218.06 | 1132.04 | 1365.69 | 1063.18 | Upgrade
|
| Cash Interest Paid | 24.68 | 37.83 | 20.1 | 8.84 | 39.51 | 57.9 | Upgrade
|
| Cash Income Tax Paid | 6,421 | 7,125 | 6,363 | 5,716 | 5,069 | 4,708 | Upgrade
|
| Levered Free Cash Flow | 19,430 | 9,760 | -4,494 | 13,094 | 17,851 | 11,643 | Upgrade
|
| Unlevered Free Cash Flow | 19,451 | 9,786 | -4,480 | 13,100 | 17,875 | 11,678 | Upgrade
|
| Change in Working Capital | 201.93 | -7,338 | -2,573 | -1,391 | 1,031 | -4,480 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.